Dow Futures Rally 800 points After Report Says Coronavirus Drug Trial Shows Encouraging Early Results

0

NEW YORK (VINnews) – U.S. stock futures surged on Thursday night after a report said a Gilead Sciences drug was showing effectiveness in treating the coronavirus. The move pointed to a jump for the stock market on Friday.

Join our WhatsApp group

Subscribe to our Daily Roundup Email


Dow Jones Industrial Average futures were up 800 points, or about 3.3%. S&P 500 futures gained 2.9% while Nasdaq 100 futures were up by 2.1%.

Gilead shares jumped by 14% in after-hours trading after STAT news reported that a Chicago hospital treating coronavirus patients with Remdesivir in a trial were recovering rapidly from severe symptoms. The publication cited a video it obtained where the trial results were discussed.


Listen to the VINnews podcast on:

iTunes | Spotify | Google Podcasts | Stitcher | Podbean | Amazon

Follow VINnews for Breaking News Updates


Connect with VINnews

Join our WhatsApp group